Evofem Biosciences, Inc. (EVFM)
OTCMKTS · Delayed Price · Currency is USD
0.0096
+0.0006 (6.67%)
Dec 26, 2024, 12:16 PM EST

Evofem Biosciences Company Description

Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women’s sexual and reproductive health.

Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100 for the prevention of chlamydia and gonorrhea in Women, and EVO200 for the prevention of recurrent bacterial vaginosis.

Evofem Biosciences, Inc. is headquartered in San Diego, California.

Evofem Biosciences, Inc.
Evofem Biosciences logo
Country United States
Industry Biotechnology
Sector Healthcare
Employees 38
CEO Saundra Pelletier

Contact Details

Address:
7770 Regents Roas
San Diego, Delaware 92122
United States
Phone 858 550 1900
Website evofem.com

Stock Details

Ticker Symbol EVFM
Exchange OTCMKTS
Fiscal Year January - December
Reporting Currency USD
ISIN Number US30048L2034
SIC Code 2834

Key Executives

Name Position
Saundra Pelletier Interim Chair, President and Chief Executive Officer
Ivy Zhang CPA Chief Financial Officer and Secretary
Amy Raskopf Chief Business Development Officer and Senior Vice President of Investor Relations
Ellen Thomas Chief of Staff
Kathy Gallo-Doyle Senior Vice President of Commercial Operations